ANDO KIYOHIRO - My portal

Profile Information

Affiliation: Nihon University School of Medicine Assistant Professor

Degree: 医学博士(日本大学)

Researcher number: 10455389
J-GLOBAL ID: 200901007636492836

Research Interests

The molecular biology of cancer

Research Areas

Life sciences / Medical biochemistry / General medical chemistry

Research History

Aug, 2017

Nihon University School of Medicine Div.of Biochemistry, Dpt. of Biomedical Science Assistant Professor
Nihon University School of Medicine, Department of Medicine Assistant Professor

Education

Apr, 2000 - Mar, 2004

Nihon University
Apr, 1992 - Mar, 1998

Nihon University 医学部医学科

Papers

An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues

Yusuke Ono, Ayumu Sugitani, Hidenori Karasaki, Munehiko Ogata, Reo Nozaki, Junpei Sasajima, Tomoki Yokochi, Shingo Asahara, Kazuya Koizumi, Kiyohiro Ando, Katsunori Hironaka, Tsutomu Daito, Yusuke Mizukami

MOLECULAR ONCOLOGY 11(10) 1448 - 1458 Oct, 2017 Peer-reviewed
NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus

Kiyohiro Ando, Melissa J. Parsons, Richa B. Shah, Chloe I. Charendoff, Shere L. Paris, Peter H. Liu, Sara R. Fassio, Brittany A. Rohrman, Ruth Thompson, Andrew Oberst, Samuel Sidi, Lisa Bouchier-Hayes

JOURNAL OF CELL BIOLOGY 216(6) 1795 - 1810 Jun, 2017 Peer-reviewed
An Inhibitor of PIDDosome Formation

Ruth Thompson, Richa B. Shah, Peter H. Liu, Yogesh K. Gupta, Kiyohiro Ando, Aneel K. Aggarwal, Samuel Sidi

MOLECULAR CELL 58(5) 767 - 779 Jun, 2015 Peer-reviewed
RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma

F. Yu, W. Gao, T. Yokochi, Y. Suenaga, K. Ando, M. Ohira, Y. Nakamura, A. Nakagawara

ONCOGENE 33(20) 2601 - 2609 May, 2014 Peer-reviewed
SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer

Lianjie Li, Chuan Shen, Eijiro Nakamura, Kiyohiro Ando, Sabina Signoretti, Rameen Beroukhim, Glenn S. Cowley, Patrick Lizotte, Ella Liberzon, Steven Bair, David E. Root, Pablo Tamayo, Aviad Tsherniak, Su-Chun Cheng, Barbara Tabak, Anders Jacobsen, A. Ari Hakimi, Nikolaus Schultz, Giovanni Ciriello, Chris Sander, James J. Hsieh, William G. Kaelin

CANCER CELL 24(6) 738 - 750 Dec, 2013 Peer-reviewed

Presentations

Possible therapeutic usage of checkpoint abrogation strategy for neuroblastoma treatment

Kiyohiro Ando

第60回日本小児血液・がん学会学術総会 Nov 14, 2018
The blockade of DNA damage response increase the sensitivity of CHK1 inhibitor in neuroblastoma

第77回日本癌学会学術総会 Sep 29, 2018
checkpoint abrogationを応用した神経芽腫治療の可能性

Kiyohiro Ando

第27回日本癌病態治療研究会 May 31, 2018

Research Projects

CHK1阻害剤の細胞死誘導の分子機構に着目した感受性遺伝子の同定と臨床応用

Apr, 2018 - Mar, 2021
Identifying predicators for therapeutic effect of CHK1 inhibitor in neuroblastoma

Apr, 2018 - Mar, 2019